Spark Investment Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-52,500
| Closed | -$456K | – | 808 |
|
|
2018
Q2 | $456K | Buy |
52,500
+18,300
| +54% | +$165K | 0.03% | 451 |
|
|
2018
Q1 | $347K | Buy |
34,200
+715
| +2% | +$6.01K | 0.02% | 446 |
|
|
2017
Q4 | $162K | Sell |
33,485
-12,315
| -27% | -$59.9K | 0.01% | 593 |
|
|
2017
Q3 | $208K | Sell |
45,800
-14,200
| -24% | -$66.7K | 0.01% | 601 |
|
|
2017
Q2 | $303K | Buy |
60,000
+14,900
| +33% | +$66.7K | 0.02% | 582 |
|
|
2017
Q1 | $214K | Sell |
45,100
-5,400
| -11% | -$27.3K | 0.01% | 699 |
|
|
2016
Q4 | $282K | Buy |
50,500
+2,100
| +4% | +$11.5K | 0.02% | 584 |
|
|
2016
Q3 | $268K | Buy |
48,400
+4,900
| +11% | +$32.4K | 0.02% | 609 |
|
|
2016
Q2 | $304K | Sell |
43,500
-9,900
| -19% | -$69.8K | 0.03% | 554 |
|
|
2016
Q1 | $352K | Buy |
53,400
+7,600
| +17% | +$55.9K | 0.04% | 519 |
|
|
2015
Q4 | $471K | Buy |
45,800
+6,600
| +17% | +$76.5K | 0.06% | 389 |
|
|
2015
Q3 | $461K | Buy |
39,200
+18,200
| +87% | +$201K | 0.06% | 392 |
|
|
2015
Q2 | $188K | Sell |
21,000
-2,500
| -11% | -$18.9K | 0.03% | 537 |
|
|
2015
Q1 | $145K | Buy |
23,500
+3,100
| +15% | +$19.2K | 0.02% | 588 |
|
|
2014
Q4 | $114K | Buy |
20,400
+2,700
| +15% | +$15.7K | 0.02% | 566 |
|
|
2014
Q3 | $104K | Buy |
+17,700
| New | +$108K | 0.02% | 591 |
|
Spark Investment Management's JNP Position: Q3 2018 in Review
Spark Investment Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 52,500 shares — an estimated $456K sold.
Spark Investment Management first reported a position in JNP in Q3 2014 and held it in 16 quarters. The position peaked at $471K in Q4 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Spark Investment Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Spark Investment Management sold 52,500 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $456K.
- Spark Investment Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2014 and held it in 16 quarters.
- Spark Investment Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $471K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Spark Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.